Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Epic American Credit and Bond Bubble Laboratory -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (36243)	7/18/2005 12:52:02 PM
From: grusum	Read Replies (1) \| Respond to of 110194

ok, thanks Henry. eom

To: Henry Niman who wrote (36243)	7/18/2005 2:38:02 PM
From: Elroy Jetson	Read Replies (1) \| Respond to of 110194

Now you're just being silly. Allergic responses, like the hyper-immune response in response to the exotoxins produced by pathogens like Strep-A, are quickly and easily halted through the use of short-acting immune suppressing drugs like Prednisone or Prednisolone. In any event, Interferon-alpha, rather than causing cytokine storms, is used to damp down cytokine storms. It signals T-Cells to sacrifice themselves to fight virus, in contrast to the signals produced by some flu variants which cause excessive T-Cell duration. google.com Researcher specializing in Flu are even developing their own special immune damping drugs which mimic some aspects of interferon-alpha. Nothing quite like re-inventing the wheel with a simulated substitute. newscientist.com .